期刊文献+

新型生物可降解雷帕霉素药物洗脱输尿管支架的构建及性能评估 被引量:3

Construction and performance evaluation of a new biodegradable rapamycin-eluting ureteral stent
下载PDF
导出
摘要 目的构建一种新型生物可降解雷帕霉素药物洗脱输尿管支架并评估其机械性能及药物释放特性。方法采用聚乳酸为原料,将其溶于氯仿后加入雷帕霉素粉末,通过溶液挥发法构建螺旋形生物可降解雷帕霉素药物洗脱输尿管支架。通过万能压力机检测新型生物可降解雷帕霉素输尿管支架力学性能,并分别在3周、6周、9周和12周时通过色谱分析仪评估其药物释放特性。结果成功构建的生物可降解雷帕霉素药物洗脱输尿管支架,长度为50 mm,内径为0.8 mm,外径1.4 mm,厚度为200μm,带宽为1 mm。支架不仅具有良好的力学性能,并可有效持续释放药物,支架平均雷帕霉素含量为2 755μg,3周后支架平均含药量为2 670μg,6周后支架平均含药量为2 533μg,9周后支架平均含药量为1 541μg,12周后支架平均含药量为744μg。结论构建的生物可降解雷帕霉素药物洗脱输尿管支架具有良好的机械性能,可有效释放药物,有望为输尿管损伤或狭窄的治疗提供一种新的简单有效的材料和方法。 Objective To construct a new biodegradable rapamycin-eluting ureteral stent and to evaluate its mechanical property and drug-eluting characteristics. Methods Polylactic was selected as the stent material and dis-solved by chloroform. The rapamycin powder was added into the solution. Then, a new helical biodegradable rapa-mycin-eluting ureteral stent was made by volatilization method. The mechanical property of the stent was measured by universal tension tester, while the drug-eluting characteristic was evaluated by chromatographic analysis ma-chine. Results The new biodegradable rapamycin-eluting ureteral stent had good mechanical property with length in 50 mm, inner diameter in 8 mm, outer diameter in 1.4 mm, thickness in 200μm and width in 1 mm. The stent can continuously release drug. The mean amount of rapamycin of the stent was 2 755 μg. After 3 weeks, the remained mean amount of rapamycin was 2 670μg. At 6 weeks, it was 2 533μg and 1 541 at 9 weeks. Eventually, it was de-creased to 744μg at 12 weeks. Conclusion The new biodegradable rapamycin-eluting ureteral stent made of polylac-tic acid not only has good mechanical property, but also can release drug efficiently, which may provide a new materi-al for the treatment of ureteral strictures.
出处 《海南医学》 CAS 2014年第18期2663-2666,共4页 Hainan Medical Journal
基金 国家自然科学基金(编号:81070555) 北京市自然科学基金资助项目(编号:7142145和2092029) 军队临床高新技术重点项目(编号:413DG63J)
关键词 生物可降解 药物洗脱支架 输尿管支架 Biodegradable Drug-eluting stent Ureteral stent
  • 相关文献

参考文献12

  • 1Chew BH, Duvdevani M, Denstedt JD. New developments in ureter- al stent design, materials and coatings [J]. Expert Rev Med Devices, 2006, 3(3): 395-403.
  • 2Ozgur BC, Ekici M, Yuceturk CN, et al. Bacterial colonization of double J stents and bacteriuria frequency [J]. Kaohsiung J Med Sci, 2013, 29(12): 658-661.
  • 3Soda F, MorciUo E, Pamplona M, et al. Evaluation in an animal model of a hybrid covered metallic ureteral stent: a new design [J]. Urology, 2013, 81(2): 458-463.
  • 4Lange D, Chew BH. Update on ureteral stent technology [J]. Ther Adv Urol, 2009, 1(3): 143-148.
  • 5Schurtz G, Delhaye C, Hurt C, et al. Biodegradable polymer Biolim- us-eluting stent (Nobod ) for the treatment of coronary artery le- sions: review of concept and clinical results [J]. Med Devices (Auckl), 2014, 27(7): 35-43.
  • 6Kukreja N, Onuma Y, Daemen J, et al. The future of drug-eluting stents [J]. Pharmacol Res, 2008, 57(3): 171-180.
  • 7Cutright DE, Perez B, Beasley JD, et al. Degradation rates of poly- mers and copolymers of polylactic and polyglycolic acids [J]. Oral Surg Oral Med Oral Pathol, 1974, 37(1): 142-152.
  • 8Kulkarni RK, Pani KC, Neuman C, et al. Polylactic acid for surgical implants [J]. Arch Surg, 1966, 93(5): 839-843.
  • 9Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents [J]. Adv Drug Deliv Rev, 2006, 58(3): 387-401.
  • 10Lewis AL, Willis SL, Small SA, et al. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo [J]. Biomed Mater Eng, 2004, 14(4): 355-370.

同被引文献21

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部